Cerebrovascular Diseases

Clinical Research in Stroke

Bridging versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke: A Subgroup Pooled Meta-Analysis for Time of Intervention, Eligibility, and Study Design

Vidale S.a · Romoli M.a · Consoli D.b · Agostoni E.C.c

Author affiliations

aDepartment of Neurology, Infermi Hospital, Rimini, Italy
bDepartment of Neurology, “G. Jazzolino” Hospital, Vibo Valentia, Italy
cDepartment of Neurology, Niguarda Ca’ Granda Hospital, Milan, Italy

Related Articles for ""

Cerebrovasc Dis 2020;49:223–232

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Clinical Research in Stroke

Received: March 09, 2020
Accepted: April 13, 2020
Published online: April 24, 2020
Issue release date: May 2020

Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 1

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: https://www.karger.com/CED

Abstract

Background and Aim: The risk/benefit profile of intravenous thrombolysis (IVT) prior to endovascular thrombectomy (EVT) in acute ischemic stroke is still unclear. We provide a systematic review and meta-analysis including studies comparing direct EVT (dEVT) vs. bridging treatment (IVT + EVT), defining the impact of treatment timing and eligibility to IVT on functional status and mortality. Methods: Protocol was registered with PROSPERO (CRD42019135915) and followed PRISMA guidelines. PubMed, EMBASE, and Cochrane Central were searched for randomized controlled trials (RCTs), retrospective, and prospective studies comparing IVT + EVT vs. dEVT in adults (≥18) with acute ischemic stroke. Primary endpoint was functional independence at 90 days (modified Rankin Scale <3); secondary endpoints were (i) good recanalization (thrombolysis in cerebral infarction >2a), (ii) mortality, and (iii) symptomatic intracranial hemorrhage (sICH). Subgroup analysis was performed according to study type, eligibility to IVT, and onset-to-groin timing (OGT), stratifying studies for similar OGT. ORs for endpoints were pooled with meta-analysis and compared between reperfusion strategies. Results: Overall, 35 studies were included (n = 9,117). No significant differences emerged comparing patients undergoing dEVT and bridging treatment for gender, hypertension, diabetes, National Institute of Health Stroke Scale score at admission. Regarding primary endpoint, IVT + EVT was superior to dEVT (OR 1.44, 95% CI 1.22–1.69, p < 0.001, pheterogeneity<0.001), with number needed to treat being 18 in favor of IVT + EVT. Results were confirmed in studies with similar OGT (OR 1.66; 95% CI 1.21–2.28), shorter OGT for IVT + EVT (OR 1.53, 95% CI 1.27–1.85), and independently from IVT eligibility (OR 1.53, 95% CI 1.29–1.82). Mortality at 90 days was higher in dEVT (OR 1.38; 95% CI 1.09–1.75), but no significant difference was noted for sICH. However, considering data from RCT only, reperfusion strategies had similar primary (OR 0.91, 95% CI 0.6–1.39) and secondary endpoints. Differences in age and clinical severity across groups were unrelated to the primary endpoint. Conclusions: Compared to dEVT, IVT + EVT associates with better functional outcome and lower mortality. Post hoc data from RCTs point to substantial equivalence of reperfusion strategies. Therefore, an adequately powered RCTs comparing dEVT versus IVT + EVT are warranted.

© 2020 S. Karger AG, Basel




Related Articles:


References

  1. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al.; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr;387(10029):1723–31.
  2. Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, et al. Endovascular thrombectomy for acute ischemic stroke. A meta-analysis. JAMA. 2015 Nov;314(17):1832–43.
  3. Rodrigues FB, Neves JB, Caldeira D, Ferro JM, Ferreira JJ, Costa J. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016 Apr;353:i1754.
  4. Vidale S, Agostoni E. Endovascular treatment of ischemic stroke. An updated meta-analysis of efficacy and safety. Vasc Endovascular Surg. 2017 May;51(4):215–9.
  5. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al.; American Heart Association Stroke Council. 2018 Guidelines for the early management of patients with acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2018 Mar;49(3):e46–110.
  6. Mistry EA, Mistry AM, Nakawah MO, Chitale RV, James RF, Volpi JJ, et al. Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patients. A meta-analysis. Stroke. 2017 Sep;48(9):2450–6.
  7. Kim CH, Jeon JP, Kim SE, Choi HJ, Cho YJ. Endovascular treatment with intravenous thrombolysis versus endovascular treatment alone for acute anterior circulation stroke: a meta-analysis of observational studies. J Korean Neurosurg Soc. 2018 Jul;61(4):467–73.
  8. Phan K, Dmytriw AA, Maingard J, Asadi H, Griessenauer CJ, Ng W, et al. Endovascular thrombectomy alone versus combined with intravenous thrombolysis. World Neurosurg. 2017 Dec;108:850–8.e2.
  9. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke. 2000 Apr;31(4):811–6.
  10. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al.; Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998 Oct;352(9136):1245–51.
  11. Kirmani J, Korya D, Mehta S, et al. Symptom onset to groin puncture determines stroke outcome a meta-analysis of recent acute cerebrovascular thrombectomy-after-infarction trials (MR ACTION). Neurology. 2016;86(Suppl 16).
  12. Abilleira S, Ribera A, Cardona P, Rubiera M, López-Cancio E, Amaro S, et al.; Catalan Stroke Code and Reperfusion Consortium. Outcomes after direct thrombectomy or combined intravenous and endovascular treatment are not different. Stroke. 2017 Feb;48(2):375–8.
  13. Balodis A, Radzina M, Miglane E, Rudd A, Millers A, Savlovskis J, et al. Endovascular thrombectomy in anterior circulation stroke and clinical value of bridging with intravenous thrombolysis. Acta Radiol. 2019 Mar;60(3):308–14.
  14. Bellwald S, Weber R, Dobrocky T, Nordmeyer H, Jung S, Hadisurya J, et al. Direct mechanical intervention versus bridging therapy in stroke patients eligible for intravenous thrombolysis. A pooled analysis of 2 registries. Stroke. 2017 Dec;48(12):3282–8.
  15. Bourcier R, Alexandre PL, Eugène F, Delasalle-Guyomarch B, Guillon B, Kerleroux B, et al. Is bridging therapy still required in stroke due to carotid artery terminus occlusions? J Neurointerv Surg. 2018 Jul;10(7):625–8.
  16. Dávalos A, Pereira VM, Chapot R, Bonafé A, Andersson T, Gralla J; Solitaire Group. Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke. 2012 Oct;43(10):2699–705.
  17. Ferrigno M, Bricout N, Leys D, Estrade L, Cordonnier C, Personnic T, et al. Intravenous recombinant tissue-type plasminogen activator. Influence on outcome in anterior circulation ischemic stroke treated by mechanical thrombectomy. Stroke. 2018 Jun;49(6):1377–85.
  18. Guedin P, Larcher A, Decroix JP, Labreuche J, Dreyfus JF, Evrard S, et al. Prior IV thrombolysis facilitates mechanical thrombectomy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2015 May;24(5):952–7.
  19. Leker RR, Pikis S, Gomori JM, Cohen JE. Is bridging necessary? A pilot study of bridging versus primary stentriever-based endovascular reperfusion in large anterior circulation strokes. J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1163–7.
  20. Maingard J, Shvarts Y, Motyer R, Thijs V, Brennan P, O’Hare A, et al. Outcomes of endovascular thrombectomy with and without bridging thrombolysis for acute large vessel occlusion ischaemic stroke. Intern Med J. 2019 Mar;49(3):345–51.
  21. Pfefferkorn T, Holtmannspötter M, Patzig M, Brückmann H, Ottomeyer C, Opherk C, et al. Preceding intravenous thrombolysis facilitates endovascular mechanical recanalization in large intracranial artery occlusion. Int J Stroke. 2012 Jan;7(1):14–8.
  22. Guimarães Rocha M, Carvalho A, Rodrigues M, Cunha A, Figueiredo S, Martins de Campos A, et al. Primary thrombectomy versus combined mechanical thrombectomy and intravenous thrombolysis in large vessel occlusion acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019 Mar;28(3):627–31.
  23. Wang H, Zi W, Hao Y, Yang D, Shi Z, Lin M, et al.; ACTUAL Investigators. Direct endovascular treatment: an alternative for bridging therapy in anterior circulation large-vessel occlusion stroke. Eur J Neurol. 2017 Jul;24(7):935–43.
  24. Coutinho JM, Liebeskind DS, Slater LA, Nogueira RG, Clark W, Dávalos A, et al. Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke. Apooled analysis of the SWIFT and STAR studies. JAMA Neurol. 2017 Mar;74(3):268–74.
  25. Maier IL, Behme D, Schnieder M, Tsogkas I, Schregel K, Kleinknecht A, et al. Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke. J Neurol Sci. 2017 Jan;372:300–4.
  26. Minnerup J, Wersching H, Teuber A, Wellmann J, Eyding J, Weber R, et al.; REVASK Investigators. Outcome after thrombectomy and intravenous thrombolysis in patients with acute ischemic stroke. A prospective observational study. Stroke. 2016 Jun;47(6):1584–92.
  27. Alonso de Leciñana M, Martínez-Sánchez P, García-Pastor A, Kawiorski MM, Calleja P, Sanz-Cuesta BE, et al. Mechanical thrombectomy in patients with medical contraindications for intravenous thrombolysis: a prospective observational study. J Neurointerv Surg. 2017 Nov;9(11):1041–6.
  28. Sallustio F, Koch G, Di Legge S, Rossi C, Rizzato B, Napolitano S, et al. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e323–31.
  29. Bhatia R, Shobha N, Menon BK, Bal SP, Kochar P, Palumbo V, et al. Combined full-dose IV and endovascular thrombolysis in acute ischaemic stroke. Int J Stroke. 2014 Dec;9(8):974–9.
  30. Weber R, Nordmeyer H, Hadisurya J, Heddier M, Stauder M, Stracke P, et al. Comparison of outcome and interventional complication rate in patients with acute stroke treated with mechanical thrombectomy with and without bridging thrombolysis. J Neurointerv Surg. 2017 Mar;9(3):229–33.
  31. Rai AT, Boo S, Buseman C, Adcock AK, Tarabishy AR, Miller MM, et al. Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes. J Neurointerv Surg. 2018 Jan;10(1):17–21.
  32. Traenka C, Jung S, Gralla J, Kurmann R, Stippich C, Simonetti BG, et al. Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke - Results from the SWISS registry. Eur Stroke J. 2018 Mar;3(1):47–56.
  33. Kass-Hout T, Kass-Hout O, Mokin M, Thesier DM, Yashar P, Orion D, et al. Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke? World Neurosurg. 2014 Sep-Oct;82(3-4):e453–8.
  34. Manceau PF, Soize S, Gawlitza M, Fabre G, Bakchine S, Durot C, et al. Is there a benefit of mechanical thrombectomy in patients with large stroke (DWI-ASPECTS ≤ 5)? Eur J Neurol. 2018 Jan;25(1):105–10.
  35. Mulder MJ, Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, et al.; MR CLEAN investigators. Treatment in patients who are not eligible for intravenous alteplase: MR CLEAN subgroup analysis. Int J Stroke. 2016 Aug;11(6):637–45.
  36. Choi JH, Im SH, Lee KJ, Koo JS, Kim BS, Shin YS. comparison of outcome after mechanical thrombectomy alone or combined intravenous thrombolysis and mechanical thrombectomy for patients with acute ischemic stroke due to large vessel occlusion. World Neurosurg. 2018 Jun;114:e165–72.
  37. Imbarrato G, Bentley J, Gordhan A. Clinical outcomes of endovascular thrombectomy in tissue plasminogen activator versus non-tissue plasminogen activator patients at primary stroke care centers. J Neurosci Rural Pract. 2018 Apr-Jun;9(2):240–4.
  38. Merlino G, Sponza M, Petralia B, Vit A, Gavrilovic V, Pellegrin A, et al. Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study. J Thromb Thrombolysis. 2017 Aug;44(2):203–9.
  39. Park HK, Chung JW, Hong JH, Jang MU, Noh HD, Park JM, et al. Preceding intravenous thrombolysis in patients receiving endovascular therapy. Cerebrovasc Dis. 2017;44(1-2):51–8.
  40. Al-Khaled M, Brüning T, Gottwald C, Roessler F, Royl G, Eckey T. Comparing outcome and recanalization results in patients with anterior circulation stroke following endovascular treatment with and without a treatment with rt-PA: A single-center study. Brain Behav. 2018 Apr;8(5):e00974.
  41. Heinrichs A, Nikoubashman O, Schürmann K, Tauber SC, Wiesmann M, Schulz JB, et al. Relevance of standard intravenous thrombolysis in endovascular stroke therapy of a tertiary stroke center. Acta Neurol Belg. 2018 Mar;118(1):105–11.
  42. Broeg-Morvay A, Mordasini P, Bernasconi C, et al. Direct mechanical intervention versus combined intravenous and mechanical intervention in large artery anterior circulation stroke: A matched-pairs analysis. Stroke. 2016 Apr;47(4):1037–44.
  43. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al.; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015 Jun;372(24):2296–306.
  44. Goyal N, Tsivgoulis G, Frei D, Turk A, Baxter B, Froehler MT, et al. Comparative safety and efficacy of combined IVT and MT with direct MT in large vessel occlusion. Neurology. 2018 Apr;90(15):e1274–82.
  45. Mistry EA, Mistry AM, Nakawah MO, Khattar NK, Fortuny EM, Cruz AS, et al. Systolic blood pressure within 24 hours after thrombectomy for acute ischemic stroke correlates with outcome. J Am Heart Assoc. 2017 May;6(5):e006167.
  46. Kaesmacher J, Mordasini P, Arnold M, López-Cancio E, Cerdá N, Boeckh-Behrens T, et al. Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg. 2019 Jan;11(1):20–7.
  47. Tsivgoulis G, Katsanos AH, Schellinger PD, Köhrmann M, Varelas P, Magoufis G, et al. Successful reperfusion with intravenous thrombolysis preceding mechanical thrombectomy in large-vessel occlusions. Stroke. 2018 Jan;49(1):232–5.

Article / Publication Details

First-Page Preview
Abstract of Clinical Research in Stroke

Received: March 09, 2020
Accepted: April 13, 2020
Published online: April 24, 2020
Issue release date: May 2020

Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 1

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: https://www.karger.com/CED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP